Tomáš Reischig

Valacyclovir Prophylaxis Versus Preemptive Valganciclovir Therapy to Prevent Cytomegalovirus Disease After Renal Transplantation

Tomáš Reischig, Pavel Jindra, Ondřej Hes et al. · American Journal of Transplantation · 2007 · 217 citations · Full text

Urology, Transplantation, Cmv Dnaemia +14

The impact of cytomegalovirus disease and asymptomatic infection on acute renal allograft rejection

Tomáš Reischig, Pavel Jindra, Miroslava Švecová et al. · Journal of Clinical Virology · 2006 · 87 citations

Transplant Rejection, Transplantation, Kidney Transplant +10

Effect of Cytomegalovirus Viremia on Subclinical Rejection or Interstitial Fibrosis and Tubular Atrophy in Protocol Biopsy at 3 Months in Renal Allograft Recipients Managed by Preemptive Therapy or Antiviral Prophylaxis

Tomáš Reischig, Pavel Jindra, Ondřej Hes et al. · Transplantation · 2009 · 79 citations

Long-Term Outcomes of Pre-emptive Valganciclovir Compared with Valacyclovir Prophylaxis for Prevention of Cytomegalovirus in Renal Transplantation

Tomáš Reischig, Petra Hřibová, Pavel Jindra et al. · Journal of the American Society of Nephrology · 2012 · 75 citations · Full text

Urology, Transplantation, Kidney Transplant +14

Valacyclovir for Cytomegalovirus Prophylaxis Reduces the Risk of Acute Renal Allograft Rejection

Tomáš Reischig, Pavel Jindra, J Mareš et al. · Transplantation · 2005 · 73 citations